BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23200536)

  • 21. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.
    Masetti R; Castelli I; Astolfi A; Bertuccio SN; Indio V; Togni M; Belotti T; Serravalle S; Tarantino G; Zecca M; Pigazzi M; Basso G; Pession A; Locatelli F
    Oncotarget; 2016 Aug; 7(35):56746-56757. PubMed ID: 27462774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonal Hematopoiesis and therapy related MDS/AML.
    Desai P; Roboz GJ
    Best Pract Res Clin Haematol; 2019 Mar; 32(1):13-23. PubMed ID: 30927970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular evaluation of CEBPA gene mutation in normal karyotype acute myeloid leukemia: a comparison of two methods and report of novel CEBPA mutations from Indian acute myeloid leukemia patients.
    Ahmad F; Rajput S; Mandava S; Das BR
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):707-15. PubMed ID: 22731647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inter-Laboratory Evaluation of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia.
    Haslam K; Catherwood MA; Dobbin E; Sproul A; Langabeer SE; Mills KI
    Mol Diagn Ther; 2016 Oct; 20(5):457-61. PubMed ID: 27342108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute myeloid leukemia: molecular pathogenesis and new therapeutic strategies].
    Goyama S
    Rinsho Ketsueki; 2016 Feb; 57(2):118-28. PubMed ID: 26935629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single base substitution mutational signatures in pediatric acute myeloid leukemia based on whole genome sequencing.
    Gunnarsson R; Yang M; Olsson-Arvidsson L; Biloglav A; Behrendtz M; Castor A; Paulsson K; Johansson B
    Leukemia; 2021 May; 35(5):1485-1489. PubMed ID: 33864028
    [No Abstract]   [Full Text] [Related]  

  • 28. The use of molecular genetics to refine prognosis in acute myeloid leukemia.
    Bhatnagar B; Garzon R
    Curr Hematol Malig Rep; 2014 Jun; 9(2):148-57. PubMed ID: 24659319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis.
    Thol F; Klesse S; Köhler L; Gabdoulline R; Kloos A; Liebich A; Wichmann M; Chaturvedi A; Fabisch J; Gaidzik VI; Paschka P; Bullinger L; Bug G; Serve H; Göhring G; Schlegelberger B; Lübbert M; Kirchner H; Wattad M; Kraemer D; Hertenstein B; Heil G; Fiedler W; Krauter J; Schlenk RF; Döhner K; Döhner H; Ganser A; Heuser M
    Leukemia; 2017 Jun; 31(6):1286-1295. PubMed ID: 27881874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomics of acute myeloid leukemia.
    Graubert TA; Mardis ER
    Cancer J; 2011; 17(6):487-91. PubMed ID: 22157292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes.
    Chesnais V; Arcangeli ML; Delette C; Rousseau A; Guermouche H; Lefevre C; Bondu S; Diop M; Cheok M; Chapuis N; Legros L; Raynaud S; Willems L; Bouscary D; Lauret E; Bernard OA; Kosmider O; Pflumio F; Fontenay M
    Blood; 2017 Jan; 129(4):484-496. PubMed ID: 27856460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutant DNA methylation regulators endow hematopoietic stem cells with the preleukemic stem cell property, a requisite of leukemia initiation and relapse.
    Tan Y; Liu H; Chen S
    Front Med; 2015 Dec; 9(4):412-20. PubMed ID: 26482067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia.
    Paguirigan AL; Smith J; Meshinchi S; Carroll M; Maley C; Radich JP
    Sci Transl Med; 2015 Apr; 7(281):281re2. PubMed ID: 25834112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolving molecular genetic landscape in acute myeloid leukaemia.
    Sanders MA; Valk PJ
    Curr Opin Hematol; 2013 Mar; 20(2):79-85. PubMed ID: 23380602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse.
    Garg M; Nagata Y; Kanojia D; Mayakonda A; Yoshida K; Haridas Keloth S; Zang ZJ; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ding LW; Alpermann T; Sun QY; Lin DC; Chien W; Madan V; Liu LZ; Tan KT; Sampath A; Venkatesan S; Inokuchi K; Wakita S; Yamaguchi H; Chng WJ; Kham SK; Yeoh AE; Sanada M; Schiller J; Kreuzer KA; Kornblau SM; Kantarjian HM; Haferlach T; Lill M; Kuo MC; Shih LY; Blau IW; Blau O; Yang H; Ogawa S; Koeffler HP
    Blood; 2015 Nov; 126(22):2491-501. PubMed ID: 26438511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations.
    Salci KR; Lee JH; Laronde S; Dingwall S; Kushwah R; Fiebig-Comyn A; Leber B; Foley R; Dal Cin A; Bhatia M
    Stem Cells; 2015 Jun; 33(6):1839-49. PubMed ID: 25764124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemia.
    Flach J; Shumilov E; Wiedemann G; Porret N; Shakhanova I; Bürki S; Legros M; Joncourt R; Pabst T; Bacher U
    Hematol Oncol; 2020 Oct; 38(4):425-431. PubMed ID: 32306411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid Leukemia.
    Wang BH; Li YH; Yu L
    Chin Med J (Engl); 2015 Sep; 128(17):2395-403. PubMed ID: 26315090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation.
    Luskin MR; Carroll M; Lieberman D; Morrissette JJD; Zhao J; Crisalli L; Roth DB; Luger SM; Porter DL; Reshef R
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):1961-1967. PubMed ID: 27478011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
    Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
    Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.